Gemcitabine and oxaliplatin (GEMOX), a promissing combination for the treatment of relapsed, advanced or metastatic non small cell lung cancer (NSCLC)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 26; no. 15_suppl; p. 19061
Main Authors Calfa, C. J., Raez, L. E., Lopes, G., Walker, G., Farfan, N., Macintyre, J., Blaya, M., Rocha-Lima, C. M.
Format Journal Article
LanguageEnglish
Published 20.05.2008
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2008.26.15_suppl.19061